Why the study?
Variability in acute heart failure risk factors reduces prediction accuracy, creating a need for a short-term predictive model to guide early therapeutic intervention in coronary heart disease patients with acute heart failure.
Can a clinical predictive model accurately predict 1-year MACE in patients with coronary heart disease combined with acute heart failure?
Can a clinical predictive model accurately predict 1-year MACE in patients with coronary heart disease combined with acute heart failure?
A novel clinical predictive model incorporating clinical and biomarker variables demonstrated good discriminative ability for predicting 1-year MACE in patients with CHD and acute heart failure.
No takes yet. Share an insight, caveat, or question.
May support 1-year MACE risk stratification in CHD with acute HF; leaves open prospective validation before clinical use.
Huang et al. (2022) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: